Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q2 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Treace Medical Concepts Second Quarter 2025 Earnings Conference Call.
Treace Medical Concepts Inc. (TMCI)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | First Eagle Investment Management Jean-Marie Eveillard | 908,029 | $5,339,211 | +82% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.73 | 60,000 | $524,064.00 | 6,796,190 | 2025-03-04 | Filing | |
| $5.31 | 50,000 | $265,630.00 | 6,523,095 | 2024-09-16 | Filing | |
| $5.96 | 84,000 | $501,034.80 | 1,223,441 | 2024-08-15 | Filing | |
| $6.00 | 85,000 | $510,314.50 | 6,473,095 | 2024-08-14 | Filing | |
| $5.88 | 45,000 | $264,600.00 | 6,388,095 | 2024-06-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.97 | 50,000 | $398,460.00 | 364,081 | 2025-03-17 | Filing | |
| $24.02 | 1,700 | $40,828.39 | 1,036,441 | 2022-11-15 | Filing | |
| $21.97 | 200 | $4,394.00 | 1,038,141 | 2022-11-15 | Filing | |
| $21.18 | 1,600 | $33,890.08 | 1,038,341 | 2022-11-15 | Filing | |
| $20.12 | 46,500 | $935,580.00 | 1,039,941 | 2022-11-15 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,099,895 | $18,227,383 | 0.05% | |
| 2. | 2,250,148 | $13,230,870 | 2.69% | |
| 3. | 1,119,581 | $6,584,188 | 0% | |
| 4. | 830,270 | $4,881,988 | 3.28% | |
| 5. | 365,393 | $2,148,511 | 0.04% |
News See All
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q1 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Treace Medical Concepts, Inc. first quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode.
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2024 Earnings Call Transcript
Operator: Welcome to the Treace Medical Concepts Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
Why Treace Medical Concepts (TMCI) Is Rallying Today
Treace provides technology that facilitates Lapiplasty bunion surgery and related midfoot deformities.
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q3 2024 Earnings Call Transcript
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q3 2024 Earnings Call Transcript November 5, 2024Treace Medical Concepts, Inc. beats earnings expectations.
Treace Medical Concepts (TMCI) Slid on Reduced Guidance
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter 2024 investor letter.
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q2 2024 Earnings Call Transcript
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q2 2024 Earnings Call Transcript August 6, 2024Treace Medical Concepts, Inc. misses on earnings expectations.
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q1 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by, and welcome to the Treace Medical Concepts First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only-mode.
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Treace Medical Concepts Fourth Quarter and Full Year 2023 Earnings Conference Call. [Operator instructions].
Does the New Anti-Obesity Medicine Affect Treace Medical Concepts (TMCI)?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” third-quarter investor letter. A copy of the same can be downloaded here.
Billionaire Hedge Funds
